| Lactose (India) Ltd | 151 Cr. | 120 | 247/84.3 | 33.4 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.36 Cr. | 1.76 | 4.33/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,137 Cr. | 380 | 479/192 | 85.7 | 24.3 | 0.18 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.6 Cr. | 44.0 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 44.0 Cr. | 30.0 | 30.5/17.0 | 105 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 52.9 Cr. | 70.3 | 134/70.1 | 14.3 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 54,177 Cr. | 1,917 | 2,286/1,275 | 21.6 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 314 Cr. | 12.9 | 19.0/10.8 | 18.8 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 19.2/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 841 Cr. | 1,780 | 1,999/635 | 29.1 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 92.8 Cr. | 18.6 | 32.0/17.0 | 25.3 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 780 Cr. | 265 | 449/219 | 6.97 | 133 | 0.94 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.33 Cr. | 2.94 | 9.28/2.11 | 4.16 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 445 Cr. | 458 | 477/152 | 67.2 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,334 Cr. | 996 | 1,565/995 | 39.2 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 55.2 Cr. | 0.27 | 1.12/0.26 | 3.63 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 38.1 Cr. | 14.5 | 26.3/7.10 | 18.6 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.85 Cr. | 9.76 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 161 Cr. | 452 | 859/443 | 9.12 | 596 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 73.0 Cr. | 73.0 | 92.5/26.1 | 138 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,233 Cr. | 1,360 | 2,452/1,345 | 44.2 | 174 | 0.76 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 20.1 Cr. | 44.0 | 88.7/36.1 | 43.7 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 13.8 Cr. | 5.51 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 15.9 Cr. | 106 | 154/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 61.1 Cr. | 112 | 112/9.41 | 42.2 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 28.5 Cr. | 37.8 | 80.0/33.0 | 46.0 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.03 Cr. | 20.1 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,487 Cr. | 547 | 1,028/492 | 27.0 | 72.4 | 0.22 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 79.8 Cr. | 18.5 | 35.9/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 10.7 Cr. | 21.0 | 43.7/17.4 | 46.4 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 90,219 Cr. | 2,186 | 3,055/2,115 | 54.2 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 210 Cr. | 365 | 524/241 | 21.6 | 123 | 1.23 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 58.8 Cr. | 41.0 | 62.6/26.7 | 91.9 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 68,395 Cr. | 1,178 | 1,365/994 | 20.0 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 149 Cr. | 239 | 303/159 | 142 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 783 Cr. | 78.4 | 123/74.0 | 20.2 | 32.6 | 1.91 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 38.8 Cr. | 29.7 | 49.7/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,516 Cr. | 1,651 | 1,902/919 | 60.4 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.03 Cr. | 0.61 | 1.45/0.55 | 101 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 202 Cr. | 26.4 | 68.0/26.0 | 13.0 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 4.45 Cr. | 7.60 | 22.2/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 128 Cr. | 5.43 | 6.57/2.82 | 297 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 61,201 Cr. | 28,725 | 37,000/25,260 | 40.6 | 1,888 | 1.65 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,316 Cr. | 697 | 972/550 | 26.3 | 226 | 0.72 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 202 Cr. | 71.8 | 100/31.3 | 56.3 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,865 Cr. | 1,588 | 1,740/606 | | 103 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,373 Cr. | 1,315 | 1,870/1,110 | 390 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 827 Cr. | 236 | 330/154 | 19.2 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,020 Cr. | 763 | 808/270 | 16.1 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,098 Cr. | 442 | 839/438 | 21.3 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,506 Cr. | 1,066 | 1,595/991 | 21.3 | 768 | 0.94 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,27,396 Cr. | 3,760 | 3,882/2,886 | 58.8 | 250 | 0.85 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 932 Cr. | 101 | 296/98.0 | | 41.3 | 0.49 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,399 Cr. | 14.8 | 24.0/14.1 | 22.3 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,297 Cr. | 530 | 1,342/525 | 59.1 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,746 Cr. | 165 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,31,052 Cr. | 1,796 | 1,910/1,547 | 37.3 | 324 | 0.89 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,429 Cr. | 550 | 791/441 | 379 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,998 Cr. | 320 | 335/175 | 37.0 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,334 Cr. | 324 | 502/265 | 40.9 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 4,939 Cr. | 195 | 260/111 | 114 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,827 Cr. | 4,271 | 6,718/4,146 | 26.6 | 340 | 2.74 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,667 Cr. | 2,245 | 2,725/1,772 | 32.9 | 335 | 0.89 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,368 Cr. | 5,639 | 6,739/4,904 | 30.5 | 373 | 2.22 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 185 Cr. | 52.4 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,737 Cr. | 4,965 | 5,993/3,701 | 32.2 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 125 Cr. | 101 | 237/81.0 | 12.9 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 1,999 Cr. | 327 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,292 Cr. | 844 | 1,998/604 | 82.1 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 20,608 Cr. | 16,078 | 19,748/10,060 | 105 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 459 Cr. | 20.4 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,080 Cr. | 898 | 1,505/660 | 10.4 | 483 | 0.67 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,240 Cr. | 40.8 | 91.7/40.5 | 29.7 | 21.8 | 0.49 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,348 Cr. | 184 | 347/162 | 23.7 | 59.3 | 0.43 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 39.7 Cr. | 24.8 | 130/23.9 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 262 Cr. | 74.3 | 177/73.9 | 128 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 94,634 Cr. | 2,071 | 2,403/1,774 | 21.9 | 430 | 0.58 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 968 Cr. | 483 | 980/476 | 12.1 | 357 | 0.37 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,215 Cr. | 1,004 | 1,040/501 | 79.4 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 904 Cr. | 871 | 1,235/596 | 18.4 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 144 Cr. | 66.7 | 116/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 636 Cr. | 132 | 227/123 | 36.1 | 104 | 2.27 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 554 Cr. | 323 | 500/265 | 20.1 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 16,581 Cr. | 1,040 | 1,250/802 | 33.4 | 414 | 0.48 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,280 Cr. | 1,804 | 1,952/1,303 | 39.4 | 243 | 0.86 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,325 Cr. | 199 | 302/193 | 30.3 | 38.0 | 1.25 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,724 Cr. | 1,448 | 1,758/1,168 | 37.1 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,404 Cr. | 82.0 | 127/57.5 | 20.7 | 59.7 | 0.98 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 746 Cr. | 91.4 | 124/67.2 | 25.2 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,354 Cr. | 255 | 350/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,904 Cr. | 235 | 457/217 | 288 | 96.9 | 0.60 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,373 Cr. | 1,610 | 2,576/1,243 | 31.3 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,505 Cr. | 349 | 498/285 | 64.5 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,166 Cr. | 542 | 621/412 | 25.8 | 164 | 0.28 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 54,177 Cr. | 1,917 | 2,286/1,275 | 21.6 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,129 Cr. | 2,543 | 3,516/1,921 | 45.2 | 101 | 1.65 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,795 Cr. | 1,686 | 2,131/1,200 | 24.0 | 610 | 1.07 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,747 Cr. | 415 | 528/359 | 29.9 | 149 | 1.20 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,007 Cr. | 1,543 | 1,910/1,097 | 50.5 | 227 | 0.48 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,05,771 Cr. | 1,267 | 1,406/1,020 | 18.3 | 432 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,479 Cr. | 222 | 322/178 | 23.3 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,097 Cr. | 1,499 | 1,673/1,310 | 22.3 | 408 | 0.87 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,909 Cr. | 1,961 | 2,641/1,551 | 25.3 | 416 | 0.30 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 275 Cr. | 95.0 | 203/94.8 | 19.7 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,706 Cr. | 161 | 191/105 | 15.6 | 107 | 0.31 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 54.7 Cr. | 33.4 | 67.7/32.6 | 19.2 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 51,326 Cr. | 384 | 425/291 | 108 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,640 Cr. | 1,625 | 2,190/1,430 | 36.2 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 112 Cr. | 70.4 | 132/70.0 | 16.4 | 49.2 | 1.71 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 332 Cr. | 146 | 205/67.8 | 31.4 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,754 Cr. | 9,087 | 10,691/6,301 | 98.4 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,858 Cr. | 641 | 843/544 | 32.8 | 118 | 0.72 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 164 Cr. | 78.7 | 137/75.2 | 8.71 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 66,711 Cr. | 5,593 | 5,868/4,492 | 28.4 | 1,116 | 0.80 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 17,375 Cr. | 884 | 1,124/725 | 27.4 | 271 | 1.25 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 441 Cr. | 756 | 1,540/755 | | 690 | 0.66 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 32,944 Cr. | 2,635 | 3,116/2,022 | 33.8 | 345 | 1.06 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,377 Cr. | 302 | 412/258 | 22.9 | 133 | 1.72 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,606 Cr. | 395 | 575/312 | 18.9 | 147 | 0.25 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,308.37 Cr | 1,152.97 | | 51.22 | 202.18 | 0.36% | 16.29% | 15.20% | 6.10 |